CA2857969A1 - (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof - Google Patents

(1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof Download PDF

Info

Publication number
CA2857969A1
CA2857969A1 CA2857969A CA2857969A CA2857969A1 CA 2857969 A1 CA2857969 A1 CA 2857969A1 CA 2857969 A CA2857969 A CA 2857969A CA 2857969 A CA2857969 A CA 2857969A CA 2857969 A1 CA2857969 A1 CA 2857969A1
Authority
CA
Canada
Prior art keywords
group
aryl
heteroaryl
cycloalkyl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2857969A
Other languages
English (en)
French (fr)
Inventor
Robert M. Moriarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DemeRx Inc
Original Assignee
DemeRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DemeRx Inc filed Critical DemeRx Inc
Publication of CA2857969A1 publication Critical patent/CA2857969A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA2857969A 2012-01-25 2013-01-23 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof Abandoned CA2857969A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261741798P 2012-01-25 2012-01-25
US61/741,798 2012-01-25
PCT/US2013/022797 WO2013112622A1 (en) 2012-01-25 2013-01-23 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof

Publications (1)

Publication Number Publication Date
CA2857969A1 true CA2857969A1 (en) 2013-08-01

Family

ID=48873876

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2857969A Abandoned CA2857969A1 (en) 2012-01-25 2013-01-23 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof

Country Status (11)

Country Link
US (2) US20130267710A1 (https=)
EP (1) EP2807158A4 (https=)
JP (1) JP2015506371A (https=)
KR (1) KR20140117380A (https=)
CN (2) CN104169279A (https=)
AU (1) AU2013212209A1 (https=)
CA (1) CA2857969A1 (https=)
HK (1) HK1204615A1 (https=)
IL (1) IL233055A (https=)
RU (1) RU2014124531A (https=)
WO (1) WO2013112622A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2942638C (en) 2013-03-15 2026-03-10 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
CA2989550C (en) * 2014-06-18 2023-08-08 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
AU2015353414B2 (en) 2014-11-26 2021-04-29 Demerx, Inc. Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646289A (en) * 1994-10-24 1997-07-08 Eli Lilly And Company Heterocyclic compounds and their preparation and use
FR2884516B1 (fr) * 2005-04-15 2007-06-22 Cerep Sa Antagonistes npy, preparation et utilisations
JP2010229097A (ja) * 2009-03-27 2010-10-14 Tohoku Univ 新規オキサゾリジン誘導体及び新規オキサゾリジン誘導体塩、並びに該オキサゾリジン誘導体塩を不斉有機分子触媒とした光学活性化合物の製造方法
JP5622019B2 (ja) * 2009-09-25 2014-11-12 国立大学法人東北大学 アミノアルコール誘導体塩構造を有する不斉有機分子触媒及び該不斉有機分子触媒を用いた光学活性化合物の製造方法
WO2013028999A1 (en) * 2011-08-24 2013-02-28 The Trustees Of Columbia University In The City Of New York Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders

Also Published As

Publication number Publication date
US20130267710A1 (en) 2013-10-10
CN104169279A (zh) 2014-11-26
RU2014124531A (ru) 2016-04-10
EP2807158A4 (en) 2015-11-18
JP2015506371A (ja) 2015-03-02
IL233055A0 (en) 2014-08-03
AU2013212209A8 (en) 2014-07-10
AU2013212209A1 (en) 2014-06-26
WO2013112622A1 (en) 2013-08-01
HK1204615A1 (en) 2015-11-27
US20180319800A1 (en) 2018-11-08
EP2807158A1 (en) 2014-12-03
CN108912117A (zh) 2018-11-30
KR20140117380A (ko) 2014-10-07
IL233055A (en) 2017-02-28

Similar Documents

Publication Publication Date Title
US20180319800A1 (en) (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
Ghavre et al. Synthesis of Amaryllidaceae constituents and unnatural derivatives
Szczesniak et al. Synthesis of polyhydroxylated quinolizidine and indolizidine scaffolds from sugar-derived lactams via a one-pot reduction/Mannich/Michael sequence
Moloney et al. The oxazolomycins: a structurally novel class of bioactive compounds
WO2004033462A2 (en) METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO [2, 3-b] FURAN AND RELATED COMPOUNDS
Lautens et al. Amphoteric Character of 2‐Vinyloxiranes: Synthetic Equivalents of β, γ‐Unsaturated Aldehydes and a Vinylogous Enolate
Lv et al. Organocatalytic asymmetric synthesis of both cis-and trans-configured pyrano [2, 3-b] chromenes via different dehydration pathways
US20160024075A1 (en) Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
Tsou et al. Enantioselective organocatalytic vinylogous aldol-cyclization cascade reaction of 3-alkylidene oxindoles with o-quinones
CA2989550A1 (en) Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
Jha et al. Organocatalytic stereoselective approach to the total synthesis of (−)-halosaline
Anwar et al. Pyrrolidine-linker-camphor assembly: bifunctional organocatalysts for efficient Michael addition of cyclohexanone to nitroolefins under neat conditions
Harada et al. Construction of Optically Active Isotwistanes and Aminocyclitols Using Chiral Cyclohexadiene as a Common Intermediate
Bretzke et al. Modular synthesis of the pyrimidine core of the manzacidins by divergent Tsuji–Trost coupling
Mizutani et al. A formal synthesis of a muscarinic M1 receptor antagonist,(-)-TAN1251A
EP1731509B1 (en) Process for producing nitrogenous 5-membered cyclic compound
Cadwallader Epimeric L-Proline Derived Imidazolone Chiral Auxiliaries for the Stereoselective Alkylative Birch Reduction of Aromatic Esters and Benzonitriles
Dirscherl et al. Synthesis and structure of a heterocyclic ansa pyrrole amino acid
Chen et al. Synthesis of 2, 3, 5, 6-tetrahydro-1-alkyl/aryl-1 H-benzo [f] chromen-3-ol derivatives from β-tetralones and α, β-unsaturated aldehydes
Shinde et al. Synthesis of novel N-cyclopentenyl-lactams using the Aubé reaction
KR101446017B1 (ko) 고 입체순도를 갖는 4-알킬-5-아릴 5-원고리 설파미데이트의 제조방법
Arai et al. Construction of Unique Heterocyclic Frameworks by Photochemical Reaction of 5-and 6-Membered Heteroaromatics
KR101299720B1 (ko) 3-아미노-5-플루오로-4-디알콕시펜탄산 에스테르의 새로운제조방법
Ma Synthetic Studies Towards the Spirocyclic Imine Moiety of Cyclic Imine Marine Toxins
KR100743256B1 (ko) 6-바이닐라이덴-헥사하이드로-파이롤리진-3-온 유도체 및그의 제조방법

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180122

FZDE Discontinued

Effective date: 20210311